Skip to content
Screener

Enovis ENOV Q2 2025 earnings

Reported August 7, 2025 · Before market open

Revenue$564.5MBeat by $25.9M
EPS$0.79Beat by $0.05
Revenue estimate$538.6M
EPS estimate$0.74

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$557.5M
EPS estimate$0.76

Financials

Q2 2025

Income statement

See full
Revenue$564.5M+7.5%
Gross profit$334.7M+15.9%
Operating income-$16.8M+62.0%
Net income-$36.7M-97.1%
EPS (diluted)-$0.64-88.2%

Balance sheet

See full
Cash & equivalents$44.1M+25.9%
Total debt$1.4B+3.7%
Total equity$2.6B-21.6%
Total assets$5.0B-7.7%

Cash flow

See full
Operating cash flow$47.8M+515%
CapEx$44.4M+12.6%

Valuation & ratios

Valuation

as of 07/04/25
See full
Market cap$1.83B-26.1%
Enterprise value$3.18B-16.0%
P/S0.8×-0.5×

Profitability

See full
Gross margin57.6%+0.4pp
Operating margin-34.7%-42.8pp
Net margin-37.8%-44.4pp

Returns & leverage

See full
Return on equity-28.2%-31.7pp
Debt / equity0.5×+0.1×
Current ratio2.3×0.0×

Segments

By product

See full
Surgical$274.0M+10.7%
Bracing and Support$120.9M+2.8%
Other Prevention and Recovery$70.8M+4.2%

By segment

See full
Reconstructive$274.0M+10.7%

FAQ

When did Enovis report Q2 2025 earnings?
Enovis (ENOV) reported Q2 2025 earnings on August 7, 2025 before market open.
What were Enovis's Q2 2025 revenue and EPS?
Enovis reported revenue of $564.5M and eps of $0.79 for Q2 2025.
Did Enovis beat estimates in Q2 2025?
Revenue beat the consensus estimate of $538.6M by $25.9M. EPS beat the consensus estimate of $0.74 by $0.05.
How did Enovis's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.5% from $525.2M a year earlier and eps grew 27.4% from $0.62.
Where can I find Enovis's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001420800-25-000029) and the 10-Q periodic report (0001420800-25-000032) directly on SEC EDGAR. The filing index links above go to sec.gov.